Zydus Lifesciences’ wholly owned subsidiary -- Zydus MedTech has incorporated a wholly owned subsidiary namely Zydus MedTech (France) SAS on April 10, 2025. Zydus MedTech (France) SAS will be acquiring the equity shares of the Amplitude Surgical SA, France.
Earlier, Zydus Lifesciences had entered into a put option agreement, share purchase agreements, and other agreements to acquire, directly or through its affiliates, a controlling stake that is 85.6% equity shares (Block Acquisition) of Amplitude Surgical SA, France from the existing shareholders at a price of 6.25 Euro per equity share aggregating to a consideration value of 256.8 million Euro.
Subject to closing of the Block Acquisition, the company would file a mandatory simplified cash tender offer for all the remaining shares in the Amplitude Surgical SA, France, at the same purchase price of 6.25 Euro per equity share of the Amplitude Surgical SA, France. If the conditions are met at the end of the tender offer, the company intends to proceed with a compulsory acquisition of the remaining shares from the minority shareholders (squeeze-out) and to delist the Amplitude Surgical SA, France.
Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1667.25 |
| Dr. Reddys Lab | 1222.00 |
| Cipla | 1239.70 |
| Zydus Lifesciences | 933.00 |
| Lupin | 2313.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: